Efficacy of sublingual allergen vaccination for respiratory allergy in children. Conclusions from one meta-analysis

Journal of Investigational Allergology and Clinical Immunology

Volumn 15, Issue 1, 2005, Pages 9-16

  Olaguibel J M ^a,b   Alvarez Puebla M J ^a  

^a Universidad Pública de Navarra   (Spain)

^b Servicio Navarro de Salud   (Spain)

Author keywords

Asthma; Children; Efficacy; Immunotherapy; Meta analysis; Rhinitis; Sublingual allergen vaccination

Indexed keywords

ALLERGEN; FLUTICASONE; GRASS POLLEN EXTRACT; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; PLACEBO; VACCINE;

ALLERGIC ASTHMA; ALLERGIC CONJUNCTIVITIS; ALLERGIC RHINITIS; ARTICLE; ASTHMA; CHILDHOOD DISEASE; CLINICAL TRIAL; COCHRANE LIBRARY; CONJUNCTIVITIS; DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS; DRUG EFFICACY; DRUG SAFETY; EMBASE; GASTROINTESTINAL SYMPTOM; GRASS; HUMAN; IMMUNOTHERAPY; MEDLINE; META ANALYSIS; OLIVE; RESPIRATORY TRACT ALLERGY; RHINITIS; SYMPTOM; SYSTEMATIC REVIEW; TREATMENT OUTCOME; URTICARIA; VACCINATION;

ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ALLERGENS; CHILD; HUMANS; RANDOMIZED CONTROLLED TRIALS; RESPIRATORY HYPERSENSITIVITY; VACCINATION;

EID: 17444420775     PISSN: 10189068     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Moller, C., Dreborg, S., Ferdousi, H. A., Halken, S., Host, A., Jacobsen, L., Koivikko, A., Koller, D. Y. Niggemann, B. Norberg, L. A., Urbanek, R., Valovirta, E. and Wahn, U. 2002. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol 109(2):251-6.
2. Durham, S. R., Ying, S., Varney, V.A., Jacobson, M.R., Sudderick, R.M., Mackay, I.S., Kay, A.B. and Hamid, Q.A. 1996. Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma. J Allergy Clin Immunol 97(6):1356-65.
3. Tabar, A. I., Garcia, B.E., Rodriguez, A., Olaguibel, J.M., Muro, M.D. and Quirce, S. 1993. A prospective safety-monitoring study of immunotherapy with biologically standardized extracts. Allergy 48(6):450-3.
4. Frew, A. J. 1993. Injection immunotherapy. British Society for Allergy and Clinical Immunology Working Party. Bmj 307(6909):919-23.
5. Bousquet, J., Lockey, R. and Malling, H. 1998. WHO Position Paper. Allergen immunotherapy: Therapeutic vaccines for allergic diseases. Allergy 53(44):3-42.
6. Passalacqua, G., and Canonica, G. W. 1996. Alternative routes for allergen-specific immunotherapy. J Investig Allergol Clin Immunol 6(2):81-7.
7. Lopez, S., Pelaez, A., Navarro, L.A., Montesinos, E., Morales, C. and Carda, C. 1994. Aluminium allergy in patients hyposensitized with aluminium-precipitated antigen extracts. Contact Dermatitis 31(1):37-40.
8. Di Rienzo, V., Pagani, A., Parmiani, S., Passalacqua, G. and Canonica, G.W 1999. Post-marketing surveillance study on the safety of sublingual immunotherapy in pediatric patients. Allergy 54(10):1110-3.
9. Malling, H. J. 2002. Is sublingual immunotherapy clinically effective? Curr Opin Allergy Clin Immunol 2(6):523-31.
10. Wilson, D. R., Torres, L.I. and Durham, S.R. 2003. Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst Rev(2):CD002893.
11. Alderson P, Green S, and Higgins JPT. Cochrane Reviewers' Handbook 4.2.2 [updated December 2003]. In: The Cochrane Library, Issue 1, 2004. Chichester, UK: John Wiley & Sons, Ltd, Alderson P, Green S, Higgins JPT, editors. Cochrane Reviewers' Handbook 4.2.2 [updated December 2003]. In: The Cochrane Library, Issue 1, 2004. Chichester, UK: John Wiley & Sons, Ltd.
12. Alderson P, Green S, and Higgins JPT. Cochrane Reviewers' Handbook 4.2.2 [updated December 2003]. In: The Cochrane Library, Issue 1, 2004. Chichester, UK: John Wiley & Sons, Ltd, Alderson P, Green S, Higgins JPT, editors. Cochrane Reviewers' Handbook 4.2.2 [updated December 2003]. In: The Cochrane Library, Issue 1, 2004. Chichester, UK: John Wiley & Sons, Ltd.
13. Almagro, E., Asensio, O., Bartolome, J.M., Bosque, M., de la Hoz, B., Dolz, I., Elorza, J., Ferreiro, M., Garcia, J.M., Losada, E. and et al. 1995. [Multicenter drug surveillance of sublingual immunotherapy in allergic patients]. Allergol Immunopathol (Madr) 23(4):153-9.
14. Andre, C., Vatrinet, C., Galvain, S., Carat, F. and Sicard, H. 2000. Safety of sublingual-swallow immunotherapy in children and adults. Int Arch Allergy Immunol 121 (3):229-34.
15. Bernardis, P., Agnoletto, M., Puccinelli, P., Parmiani, S. and Pozzan, M. 1996. Injective versus sublingual immunotherapy in Alternaria tenuis allergic patients. J Investig Allergol Clin Immunol 6(1):55-62.
16. Di Rienzo, V., Puccinelli, P., Frati, F. and Parmiani, S. 1999. Grass pollen specific sublingual/swallow immunotherapy in children: open-controlled comparison among different treatment protocols. Allergol Immunopathol (Madr) 27(3):145-51.
17. DiRienzo, V., Marcucci, F., Puccinelli, P., Parmiani, S., Frati, F. Sensi, L., Canonica, G.W. and Passalacqua, G. 2003. Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study. Clin Exp Allergy 33(2):206-10.
18. Mastrandrea, F., Serio, G., Minelli, M., Minardi, A., Scarcia, G., Coradduzza, G. and Parmiani, S. 2000. Specific sublingual immunotherapy in atopic dermatitis. Results of a 6-year follow-up of 35 consecutive patients. Allergol Immunopathol (Madr) 28(2):54-62.
19. Tan, M. G., Mancino, M., Madonna, F., Buzzoni, L. and Parmiani, S. 1994. Immunologic evaluation of 24 month course of sublingual immunotherapy. Allergol Immunopathol (Madr) 22(5):209-16.
20. Yuksel, H., Tanac, R., Gousseinov, A. and Demir, E. 1999. Sublingual immunotherapy and influence on urinary leukotrienes in seasonal pediatric allergy. J Investig Allergol Clin Immunol 9(5):305-13.
21. Bahceciler, N. N., Isik, U., Barlan, I.B. and Basaran, M.M. 2001. Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study. Pediatr Pulmonol 32(1):49-55.
22. Hirsch, T., Sahn, M. and Leupold, W. 1997. Double-blind placebo-controlled study of sublingual immunotherapy with house dust mite extract (D.pt.) in children. Pediatr Allergy Immunol 8(1):21-7.
23. La Rosa, M., Ranno, C., Andre, C., Carat, F., Tosca, M.A. and Canonica, G.W. 1999. Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 104(2 Pt 1):425-32.
24. Pajno, G. B., Morabito, L., Barberio, G. and Parmiani, S. 2000. Clinical and immunologic effects of long-term sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, placebo-controlled study. Allergy 55(9):842-9.
25. Tari, M. G., Mancino, M. and Monti, G. 1990. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double-blind study. Allergol Immunopathol (Madr) 18(5):277-84.
26. Vourdas, D., Syrigou, E., Potamianou, P., Carat, F., Batard, T., Andre, C. and P S. Papageorgiou. 1998. Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization. Allergy 53(7):662-72.
27. Wuthrich, B., Bucher, C., Jorg, W., Bircher, A., Eng, P., Schneider, Y., Schnyder, F., Eigenmann, P., and Senti, G. 2003. Double-blind, placebo-controlled study with sublingual immunotherapy in children with seasonal allergic rhinitis to grass pollen. J Investig Allergol Clin Immunol 13(3):145-8.
28. Pajno, G. B., Vita, D., Parmiani, S., Caminiti, L., La Grutta, S. and Barberio, G. 2003. Impact of sublingual immunotherapy on seasonal asthma and skin reactivity in children allergic to Parietaria pollen treated with inhaled fluticasone propionate. Clin Exp Allergy 33(12):1641-7.
29. Grosclaude, M., Bouillot, P., Alt, R., Leynadier, F., Scheinmann, P., Rufin, P., Basset, D., Fadel, R. and Andre, C. 2002. Safety of various dosage regimens during induction of sublingual immunotherapy. A preliminary study. Int Arch Allergy Immunol 129(3):248-53.
30. Lombardi, C., Gargioni, S., Melchiorre, A., Tiri, A., Falagiani, P., Canonica, G.W. and Passalacqua, G. 2001. Safety of sublingual immunotherapy with monomeric allergoid in adults: multicenter post-marketing surveillance study. Allergy 56(10):989-92.
31. Olaguibel, J. M. Misclasification of a clinical trial. Change of results, http://www.update-software.com/ccng/ccng.exe?
32. Canonica, G. W., and Passalacqua, G. 2003. Noninjection routes for immunotherapy. J Allergy Clin Immunol 111(3):437-48; quiz 449.
33. Olaguibel, J. M., Tabar, A.I., Garcia Figueroa, B.E. and Cortes, C. 1997. Immunotherapy with standardized extract of Dermatophagoides pteronyssinus in bronchial asthma: a dose-titration study. Allergy 52(2):168-78.
34. Des Roches, A., Paradis, L., Knani, J., Hejjaoui, A., Dhivert, H., Chanez, P., and Bousquet, J. 1996. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. V. Duration of the efficacy of immunotherapy after its cessation. Allergy 51(6):430-3.